1-888-210-9968 • 24/7 1-888-210-9968 • 24/7 GET FREE ADVICE
The call is free. The advice is free.
Looking for Answers?

Have you or your son developed gynecomastia, or breast growth after taking Risperdal?

Wondering about your legal options?

We can help.Ā  Contact us to find out the deadline for filing a claim in the United States.

Free Case Review

  • This field is for validation purposes and should be left unchanged.

You pay us nothing unless we win your case.

  • You Have Questions
  • We Have Answers
  • We Get Results

Study Shows A 69% Higher Risk Of Risperdal Gynecomastia Side Effects

Written by on December 30, 2014
Tweet about this on TwitterShare on Facebook0Share on Google+0

In March 2014, attendees at the annual meeting of the American Association for Geriatric Psychiatry heard the results from a Canadian study reporting on a potential link between Risperdal and gynecomastia. The attendees were told that use of the drug appeared to have a causal relationship with the condition; it stimulated breast growth in men. The data showed a 69% higher risk of the disorder when compared to non-use.

A growing number of families are learning about the danger firsthand. Parents have watched their sons develop gynecomastia after taking the controversial antipsychotic. Wives have watched their husbands endure the same experience.

Many of these families have since contacted drug injury lawyers to file a Risperdal settlement claim. They claim the drug’s manufacturer, Johnson & Johnson, neglected to provide them with sufficient warning regarding the risks. At the same time, according to claimants, the company used overly-aggressive marketing tactics to increase the odds that physicians would prescribe the drug for children.

If your family has suffered injury due to Risperdal and gynecomastia, contact our offices at 1-888-210-9968. You may be eligible to file a claim for compensation and join the growing litigation targeting the manufacturer.

Scientists Find A High Relative Risk Of Risperdal Gynecomastia

Results from the aforementioned study were compiled by researchers at the University of British Columbia. Led by epidemiologist Dr. Mahyar Etminan, the team examined 1 million records for men between the ages of 45 and 80. A significant percentage of the men had taken Risperdal (risperidone) or a competing drug called Invega (paliperidone). The records reflected health-related claims made between 2001 and 2011; they were retrieved from an IMS LifeLink Health Plan database.

Dr. Etminan and his team found 8,285 occurrences of gynecomastia. For each incident, they identified 10 cases in which subjects had not developed the condition (i.e. 82,850 total). The latter group served as a control group in helping to determine the incidence rate of gynecomastia associated with use of risperidone and paliperidone.

The researchers discovered that men taking risperidone appeared to be exposed to a 69% increased risk of breast growth compared to men who didn’t take the drug. They also found that the risk was higher compared to the risk associated with quetiapine or olanzapine, two other antipsychotics.

Male Breast Growth In Risperdal Users Attributed To Hormone Changes

Scientists have long suspected that exposure to Risperdal increases the level of a hormone called prolactin in the blood (a condition called hyperprolactinemia).1 Prolactin is made and released by the pituitary gland. It is often found in high levels among women who are pregnant or breastfeeding.

Hundreds of reports describe young boys who have developed breast tissue after taking Risperdal. In many cases, they have also experienced symptoms related to lactation, similar to nursing women.

Gynecomastia side effects can cause emotional and psychological trauma in adolescent boys. Studies have shown that it impacts the way they socialize with their peers; it adversely affects their mental health and self-esteem; and it can lead to eating disorders, setting the stage for obesity and its attendant side effects. Some young men have resorted to undergoing a mastectomy to have their breasts removed.

Risperdal Lawsuits Filed After Young Boys Develop Breasts

Johnson & Johnson, along with its subsidiary Janssen, is now under intense scrutiny with regard to how it promoted Risperdal and whether it was forthcoming enough about its risks. Many parents have filed lawsuits alleging that J&J not only failed to adequately inform them, but may have purposefully concealed the dangers.

The growing litigation does not address whether Risprdal can be effective for treating select mental illnesses, such as bipolar disorder and schizophrenia. The question is whether the manufacturers used a reasonable level of care in designing and promoting the drug. Hundreds of lawsuits claim they failed to do so.

If your family has been negatively affected by Risperdal and gynecomastia, call 1-888-210-9968 today to learn about your legal rights. Our Risperdal attorneys will review your case and help you to understand your options. The consultation is free and without obligation. If you decide to file a lawsuit, there are no legal fees unless we win compensation for you.

There is limited time to file a Risperdal Gynecomastia claim. Contact our Risperdal attorneys at your earliest convenience about pursuing the compensation you and your family deserve.

1. Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management
Author Image
Attorney Stephen Fields believes that all people harmed by dangerous drugs and devices should be fairly compensated for their injuries. With this goal in mind he founded the Fields Law Firm, where he strives to achieve the best possible outcomes for his clients. Connect with Stephen via .
Nationwide Claims Help

Click on your state for more information or call 1-888-210-9968.

AL AK AZ AR CA CO CT DE FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY DC